Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Journal of antimicrobial chemotherapy

Showing results (1-10 of 15,673) with videos related to

Pageof 1,568
Sort By:
The Journal of Antimicrobial Chemotherapy|September 5, 2001
Incidence and risk factors for the development of indinavir-associated renal complicationsJ S Herman, N J Ives, M Nelson, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2001
Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniaeK Nagai, T A Davies, B E Dewasse, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2001
CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000)F Navarro, E Perez-Trallero, J M Marimon, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2001
In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniaeN Miyashita, H Fukano, Y Niki, et al.
The Journal of Antimicrobial Chemotherapy|September 22, 2001
Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycinR Leclercq
The Journal of Antimicrobial Chemotherapy|September 1, 1979
Effects of low ampicillin concentrations on penicillin sensitive and beta-lactamase producing strains of Neisseria gonorrhoeaeT Elmros, S Holm, E Kjellberg, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2001
The problem with cephalosporinsS J Dancer
The Journal of Antimicrobial Chemotherapy|October 3, 2001
Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCRA Solari, S Ortíz, A Soto, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2001
Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitroV Krcmery, M Huttova, F Mateicka, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2001
Cefepime versus cefotaxime for empirical treatment of bacterial pneumonia in HIV-infected patients: an open, randomized trialE Cordero, E Bouza, I Ruiz, et al.
Pageof 1,568

Showing results (1-10 of 15,673) with videos related to

Sort By:
Pageof 1,568
The Journal of Antimicrobial Chemotherapy|September 5, 2001
Incidence and risk factors for the development of indinavir-associated renal complicationsJ S Herman, N J Ives, M Nelson, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2001
Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniaeK Nagai, T A Davies, B E Dewasse, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2001
CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000)F Navarro, E Perez-Trallero, J M Marimon, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2001
In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniaeN Miyashita, H Fukano, Y Niki, et al.
The Journal of Antimicrobial Chemotherapy|September 22, 2001
Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycinR Leclercq
The Journal of Antimicrobial Chemotherapy|September 1, 1979
Effects of low ampicillin concentrations on penicillin sensitive and beta-lactamase producing strains of Neisseria gonorrhoeaeT Elmros, S Holm, E Kjellberg, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2001
The problem with cephalosporinsS J Dancer
The Journal of Antimicrobial Chemotherapy|October 3, 2001
Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCRA Solari, S Ortíz, A Soto, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2001
Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitroV Krcmery, M Huttova, F Mateicka, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2001
Cefepime versus cefotaxime for empirical treatment of bacterial pneumonia in HIV-infected patients: an open, randomized trialE Cordero, E Bouza, I Ruiz, et al.
Pageof 1,568